首页|恒古骨伤愈合剂联合桃红四物汤治疗四肢骨折术后患者的效果

恒古骨伤愈合剂联合桃红四物汤治疗四肢骨折术后患者的效果

扫码查看
目的:观察恒古骨伤愈合剂联合桃红四物汤治疗四肢骨折术后患者的效果.方法:回顾性分析 2020 年 1 月至 2023 年 1 月该院收治的 76 例四肢骨折术后患者的临床资料,按照治疗方法不同将其分为对照组 37 例和观察组 39 例.两组均行内固定术治疗,对照组术后予以桃红四物汤治疗,观察组在对照组基础上联合恒古骨伤愈合剂治疗,两组均连续治疗 1 个月.比较两组临床疗效,肿胀消退时间,骨折愈合时间,治疗前后疼痛[视觉模拟评分法(VAS)]评分、肢体运动功能[Fugl-Meyer运动功能评定量表(FMA)]评分、骨代谢指标[骨钙素(BGP)、Ⅰ型前胶原羧基末端肽(PⅠCP)、成纤维生长因子-2(FGF-2)]水平,以及不良反应发生率.结果:观察组治疗总有效率为 94.87%(37/39),高于对照组的 72.97%(27/37),差异有统计学意义(P<0.05);观察组肿胀消退时间、骨折愈合时间均短于对照组,差异有统计学意义(P<0.05);治疗后,观察组VAS评分低于对照组,差异有统计学意义(P<0.05);治疗后 3 个月,观察组FMA评分高于对照组,差异有统计学意义(P<0.05);治疗后,观察组BGP、FGF-2 水平均高于对照组,PⅠCP水平低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:恒古骨伤愈合剂联合桃红四物汤治疗四肢骨折术后患者可提高治疗总有效率和肢体运动功能评分,缩短肿胀消退时间和骨折愈合时间,改善骨代谢指标水平,降低疼痛评分,效果优于单纯桃红四物汤治疗.
Effects of Henggu Bone healing agent combined with Taohong Siwu decoction in treatment of postoperative patients with limb fractures
Objective:To observe effects of Henggu Bone healing agent combined with Taohong Siwu decoction in treatment of postoperative patients with limb fractures.Methods:The clinical data of 76 patients with limb fractures treated in this hospital from January 2020 to January 2023 were retrospectively analyzed.According to different treatment methods,they were divided into control group(37 cases)and observation group(39 cases).Both groups were treated with internal fixation.The control group was treated with Taohong Siwu decoction after the surgery,while the observation group was treated with Henggu bone healing agent on the basis of that of the control group.Both groups were treated continuously for 1 month.The clinical efficacy,the swelling regression time,the fracture healing time,the pain[visual analogue scale(VAS)]score,the limb motor function[Fugl-Meyer motor assessment(FMA)]score,the bone metabolism indexes[osteocalcin(BGP),typeⅠprocollagen carboxy terminal peptide(PⅠCP),fibroblast growth factor-2(FGF-2)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 94.87%(37/39),which was higher than 72.97%(27/37)of the control group,and the difference was statistically significant(P<0.05).The swelling regression time and the fracture healing time of the observation group were shorter than those of the control group,and the differences were statistically significant(P<0.05).After the treatment,the VAS score of the observation group was lower than that of the control group,and the difference was statistically significant(P<0.05).After 3 months of treatment,the FMA score of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of BGP and FGF-2 in the observation group were higher than those in the control group,the level of PⅠCP was lower than that in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Henggu bone healing agent combined with Taohong Siwu decoction can improve the total effective rate and the limb motor function scores,shorten the swelling regression time and the fracture healing time,improve the levels of bone metabolism indexes and reduce the pain scores in the postoperative patients with limb fractures.Moreover,it is superior to single Taohong Siwu decoction treatment.

Limb fractureHenggu bone healing agentTaohong Siwu decoctionLimb motor functionPainBone metabolismAdverse reaction

刘昱澎

展开 >

河南省第二人民医院骨二科,河南 郑州 451191

四肢骨折 恒古骨伤愈合剂 桃红四物汤 肢体运动功能 疼痛 骨代谢 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(1)
  • 10